Clinical Study
Assessment of the Safety and Efficacy of a Raft-Forming Alginate Reflux Suppressant (Liquid Gaviscon) for the Treatment of Heartburn during Pregnancy
Table 1
Previous pregnancy details of patients (safety population).
| Number of patients | 142 |
| Number of previous pregnancies | | Range | 0–9 | 0 | 36 (25%) | 1 | 61 (43%) | 2 | 21 (15%) | 3 or more | 24 (17%) |
| Number of previous pregnancies to term | | Range | 0–8 | 0 | 52 (37%) | 1 | 58 (41%) | 2 | 22 (15%) | 3 or more | 10 (7%) |
| Number of previous pregnancies not to term | | Range | 0–4 | 0 | 107 (75%) | 1 | 26 (18%) | 2 | 5 (4%) | 3 or more | 4 (3%) |
|
|